Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gilead Sciences
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Individuals who were or are being treated for refractory Follicular Lymphoma (FL) according to the product information for idelalisib and treatment guidelines in routine clinical practice.
You may not be if
Individuals included in clinical trials on idelalisib within the timeframe of this study.
Clareo Health | Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma
